HRMY
Harmony Biosciences Holdings, Inc.
October 22, 2026 · intraday
- Rarity
- 2.15
- Peak move
- −10.36%
- Float cap
- $1.9B
Harmony Biosciences Holdings, Inc. is a neuroscience company focused on rare neurological diseases. It commercializes WAKIX (pitolisant), an FDA-approved oral treatment for excessive daytime sleepiness and cataplexy in patients with narcolepsy, and is developing therapies for idiopathic hypersomnia, Prader-Willi syndrome, rare epilepsies, and other central nervous system disorders.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.